Stay updated on Pembrolizumab in Endometrial Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Endometrial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Endometrial Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.1 to v3.4.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-13T11:57:16.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1 on the page footer; no substantive changes to study data, eligibility criteria, or results are evident. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-06T09:12:08.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    The page's revision label updates from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-15T04:51:02.000Z thumbnail image
  5. Check
    62 days ago
    Change Detected
    Summary
    Added a Locations section listing Connecticut as a study site and removed the older Connecticut Locations entry and the HHS Vulnerability Disclosure in the prior revision.
    Difference
    0.2%
    Check dated 2025-12-24T14:43:03.000Z thumbnail image
  6. Check
    85 days ago
    Change Detected
    Summary
    Page revision updated from v3.3.1 to v3.3.2 with no visible changes to study content or layout. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T17:54:08.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    A note clarifying that publications are automatically filled from PubMed was added, and the page revision tag was updated to v3.3.1. The previous PubMed-related note and the older revision tag (v3.2.0) were removed.
    Difference
    0.1%
    Check dated 2025-11-24T14:53:03.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Endometrial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Endometrial Cancer Clinical Trial page.